Price Ben Gil Insider Trading Activity

Average Profitability
41.98%
Insider Buys Quantity
10
Insider Buys Sum
$272,891.37
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Price Ben Gil

Biography of Price Ben Gil

No biography is available at this moment.

2016-03-14PurchaseSarepta Therapeutics, Inc.
SRPT
director
4,500
0.0099%
$16.70$75,144+66.5%
2013-08-19PurchaseSarepta Therapeutics, Inc.
SRPT
director
500
0.0015%
$31.18$15,588-9.51%
2012-03-14PurchaseSarepta Therapeutics, Inc.
SRPT
director
30,000
0.0217%
$1.29$38,850+82.07%
2011-04-06PurchaseSarepta Therapeutics, Inc.
SRPT
director
20,000
0.0142%
$1.50$30,000-27.53%
2010-08-13PurchaseSarepta Therapeutics, Inc.
SRPT
director
4,000
0.0036%
$1.93$7,720-3.14%
2010-06-11PurchaseSarepta Therapeutics, Inc.
SRPT
director
7,000
0.0063%
$1.44$10,080+29.66%
2010-05-13PurchaseSarepta Therapeutics, Inc.
SRPT
director
40,000
0.0355%
$1.36$54,400+35.25%
2009-03-16PurchaseSarepta Therapeutics, Inc.
SRPT
director
20,400
0.025%
$0.67$13,703+120.59%
2009-03-13PurchaseSarepta Therapeutics, Inc.
SRPT
director
30,000
0.0375%
$0.65$19,377+134.38%
2008-08-15PurchaseSarepta Therapeutics, Inc.
SRPT
director
6,582
0.0093%
$1.22$8,030-19.83%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.